IRCT20121212011738N3
The effect of Montelukast in reducing disease recurrence in patients with ulcerative colitis
Determining the effect of Montelukast in reducing disease recurrence in patients with moderate to severe ulcerative colitis during the period of gradual reduction of glucocorticoid dose.
Tabriz University of Medical Sciences·Phase 3·Iranian Registry Of Clinical Trial·drugCompleted
Study focus
- Disease/Condition
- Ulcerative colitis
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Tabriz University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- Phase 3
- Start date
- Oct 12, 2022
- End date
- N/A
ICD-10 classifications
Ulcerative colitisOther ulcerative colitisUlcerative colitis, unspecifiedArthropathy in ulcerative colitisJuvenile arthritis in ulcerative colitis
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20121212011738N3
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20121212011738N3 through Pure Global AI's free database. This Phase 3 trial is sponsored by Tabriz University of Medical Sciences and is currently Completed. The study focuses on Ulcerative colitis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.